My point was more that anyone who expected new data today was setting himself up for disappointment. Dr. Missling isn’t going to go into complex and novel scientific data to an audience that primarily cares about future cash flow, just as he’s not going to CTAD to talk about profit potential. Know your audience.
Anyone who is disappointed by today is free to sell shares to those who have the ability to be patient. All attention now should be turned to Rett, because that is the next data milestone to be announced.
I feel for anyone who bought in or planned to exit today for big profits. Lots of hype, but fortunately it doesn’t require a PhD to read the room. I suspect that Dr. Missling may have a surprise or two today, it just won’t be the big data reveal many hoped for, and that’s okay. Life goes on and Anavex may end up with a few more big institutional investors joining the party if they feel the investment has been de-risked over the last 3 months
News 
Market Data 
Discover 
